About nference
nference is a healthcare AI company that serves as the intelligence layer for clinical research, partnering with leading medical centers to unlock the value of real-world data. The company operates a federated AI network that connects healthcare data across institutions while maintaining patient privacy through its 'Data Under Glass' approach, ensuring data remains within health centers' premises. nference's platform processes over 10 billion radiology images, 20 million digitized pathology slides, 12 million ECG waveforms, 100 million echocardiogram videos, and 1.4 billion clinical notes to create the world's most comprehensive research-ready patient dataset. The company's nSights platform leverages agentic AI, neural networks, natural language processing, and large language models to transform unstructured EMR data into curated, computable insights. nference serves both life sciences companies and health systems, enabling regulatory-grade cohort design, patient journey analysis, biomarker discovery, and advanced statistical analytics across therapeutic areas including cardiology, oncology, immunology, rare diseases, neurology, infectious diseases, and nephrology. The company has also launched venture-backed spinouts including Anumana (ECG-based predictive diagnostics) and Pramana (digital pathology solutions). Founded by CEO Murali Aravamudan and Chief Scientific Officer Dr. Venky Soundararajan, nference is headquartered in Cambridge, Massachusetts, with additional offices in Bangalore, Toronto, and Rochester.
Mission & Story
Mission
Powering quantum leaps in human health
Founding Story
nference was founded by Murali Aravamudan and Venky Soundararajan, PhD, with the belief that the greatest opportunity for their generation to elevate human health is by developing technology to curate and synthesize the world's biomedical data to enable scientific discovery. The exponential growth of biomedical data driven by EMR adoption provided an unprecedented opportunity to create transformative healthcare technologies.
Clinical Focus
Medical conditions and clinical areas addressed by nference.
Who It Serves
Milestones & Awards
Recent Milestones
Launched venture spinouts Anumana (ECG-based predictive diagnostics) and Pramana (digital pathology platform). Published research on GLP-1 therapies and lean muscle mass preservation (2025-2026). Recognized as one of the best places to work by Tech Tribune (2020-2023).
Awards & Recognition
Tech Tribune Best Places to Work 2020, 2021, 2022, 2023
Key Partnerships
Company Details
- Headquarters
- Cambridge, MA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.